TCT-803 Influence of stent surface microstructuring on endothelial cell migration and substrate thrombogenicity  by Nothhaft, Matthias et al.
TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM www.jacctctabstracts2013.com
P
O
S
T
E
R
STCT-803
Inﬂuence of stent surface microstructuring on endothelial cell migration and
substrate thrombogenicity
Matthias Nothhaft1, Christoph Lutter1, Alexander Rzany2, Iwona Cicha1,
Christoph Garlichs1
1University Hospital of Erlangen-Nuremberg, Erlangen, Germany, 2Max Schaldach-
Stiftungsprofessur for Biomedical Research, University of Erlangen-Nuremberg,
Erlangen, Erlangen, Germany
Background: Coronary stent implantation is currently one of the most performed
cardiovascular interventions, but requires a long-term therapy with anti-platelet agents
to prevent stent thrombosis. Stents with microstructured surfaces should improve stent
vascularisation, reduce thrombotic events and consequentially shorten the length of
anti-thrombotic therapy.
Methods: Differently designed, 2-5 mm high elevations or hollows were litho-
graphically etched on silicon plates, subsequently coated with silicon carbide. As
controls, smooth silicon plates, bare metal substrates, and cell culture plastic were
used. The migration of human umbilical vein endothelial cell (HUVECs) was
assessed in a modiﬁed barrier assay using cell culture inserts (n¼10). 8h/24h after
cell seeding, inserts were removed and cell migration was monitored for 2, 20, 30,
40, 60, and 72 hours. Actin cytoskeleton was visualised with green phalloidin.
Platelet concentrate or whole blood were incubated on the different surfaces in static
and ﬂow conditions to investigate surface thrombogenicity (n¼10). For cell
counting, P-selectin antibody conjugated with ﬂuorescein was used. Images were
taken with an incident light ﬂuorescent microscope used for studies of non-trans-
parent objects.
Results: Comparing different types of structured surfaces, improved endothelial cell
migration over 72h was observed for 4-5 mm pillow-like structures, whereas smaller
spiky structures (2 mm), hollows, and smooth surfaces (i.e. smooth silicon plates, bare
metal substrates) had a negative effect on endothelial migration. Moreover, substrate
speciﬁc interactions between the tested endothelial cells and the structure relief could
be detected. The thrombogenicity assays under static and ﬂow conditions performed
using whole blood and platelet concentrate showed that the platelet adhesion was
reduced on larger structures as compared to smaller sharp-edged structures, hollows,
or the smooth surfaces.
Conclusions: Microstructured surfaces have strong inﬂuence on endothelial cell
migration and platelet adhesion. These results open new possibilities to design stent
surfaces which improve adherence and migration of endothelial cells, and inhibit
thrombogenic processes.
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Background: This study was conducted to evaluate the endothelialization and the
inﬂammatory responses depending on the administration duration of triple anti-platelet
therapy at overlapping bioabsorbable polymer coated biolimus-eluting stents (BESs)
in a porcine coronary model.
Methods: We successfully deployed 36 overlapping BESs for the left anterior
descending coronary and left circumﬂex artery or right coronary artery in 18 non-
injured pigs. Total pigs were divided into 3 groups (12 overlapping stents of 6 pigs in
each group) as follows: group I received aspirin 100mg and clopidogrel 75mg daily
for 8 weeks, group II received aspirin 100mg and clopidogrel 75mg daily for 8 weeks
and cilostazol 200mg daily for initial 4 weeks, group III received aspirin 100mg,
clopidogrel 75mg, and cilostazol 200mg daily for 8 weeks. Follow-up coronary
angiograms and histomorphometric and histopahtologic analyses at overlapping and
non-overlapping segments were performed respectively.
Results: Inﬂammation score was similar between overlapping and non-over-
lapping segments in all pigs (1.20.33 vs. 1.10.17, p¼0.117). The neointima
area (NA) and percent area stenosis (%AS) at overlapping segments were not
signiﬁcantly different among 3 groups. However, at non-overlapping segments,
NA and %AS in group III were signiﬁcantly smaller than those in group I
(2.30.50 mm2 vs. 1.80.43 mm2, p¼0.037; 48.912.85 % vs. 37.79.08 %,
p¼0.031).
Conclusions: Our study shows that BES appears to be reliable on the inﬂammatory
response at overlapping segments as well as non-overlapping segments. Long-term
administration of cilostazol is more effective in reducing neointimal formation at non-
overlapping segments of BESs in a porcine coronary model.B244 JACC Vol 62/18/Suppl B j October 27–November 1, 2013 jTCT-805
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Background: Renal sympathetic denervation (RDN) has been shown to
sustainably reduce BP. We report preclinical results using perivascular (adventitial)
injection of small volumes of dehydrated alcohol (EtOH) via a novel drug delivery
catheter.
Methods: The three-needle delivery device, (Peregrine System, Ablative Solutions,
Inc.) was introduced via the femoral artery into renal arteries of swine using ﬂuoro-
scopic guidance. Following deployment of the needles into the perivascular space,
EtOH was injected circumferentially. Three doses of EtOH/renal artery (0.15, 0.30,
and 0.60 ml) and sham (0.4 ml saline) control were evaluated at 2-weeks. The 0.3 ml
dose was studied at 3-mos. (n¼6). Renal tissue norepinephrine (NE) was used as
a surrogate marker of the effectiveness of RDN. Renal NE was also measured in 20
(naive control) kidneys.
Results: Histopathology at 2-wks, and 3-mos. revealed substantial circumferential
sympathetic nerve injury, at 2–10 mm depth from the intima. At 3-mos, the nerves
exhibited a range of injury from focal regions of nerve swelling with minimal
cellular inﬁltrates to almost complete neurolysis (typically replaced with ﬁbrous
tissue). The injury and the NE levels reduction were dose-dependent, with highly
signiﬁcant NE reductions at all doses compared to the sham and naïve groups. At 2
weeks, the mean renal NE reductions were 52%, 77% and 87%, respectively for
the 3 doses (p < 0.01). At 3 mos. the 0.3 ml dose showed a mean renal NE
reduction of 69% compared to the controls (p < 0.01). Angiographically, there was
no evidence of vascular injury, stenosis or negative remodeling at any time point.
Histopathology conﬁrmed that the integrity of the renal artery was maintained, and
at 3 months the treated area appeared healthy and with advanced healing. There
were no systemic or renal toxic effects noted in any animal. Safety was further
conﬁrmed in a separate study in which 0.6 ml of EtOH was injected directly into
each r
Conclusions: Circumferential and deep peri-adventitial delivery of low doses of EtOH
appears to be a simple, safe, predictable and viable alternative to energy-based systems
to achieve substantial, sustained renal sympathetic denervation.
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Background: Late stent thrombosis and long-term dual antiplatelet therapy (DAPT)
are limitations of current drug-eluting stents (DES), and restenosis remains the
limitation of bare-metal stents (BMS). The COBRA PzF stent (CeloNova BioSci-
ences, San Antonio, TX) with Polyzene-F (PzF) surface modiﬁcation was
designed to resist thrombosis and inﬂammation. We assessed the thrombogenicity of
the COBRA PzF stent compared to COBRA BMS and Multi-Link Vision in the
swine shunt model.
Methods: A total of 12 stents (6 COBRA PzF stents, 3 COBRA BMS, and 3
Vision BMS) were deployed to custom-made elastic silicone tubes (SYLGARD-
184), in swine. An ex vivo arterio-venous shunt model was established with the
tubing containing stents and maintained at 37C. Following continuous 1 hr blood
ﬂow, the stents were ﬁxed with 10% formalin. Each stent was bisected longitu-
dinally and one half of the stent was submitted for immunohistochemistry using an
antibody against platelet (CD61 and CD42b), and evaluated by confocal micros-
copy while the other half of the stent was process for scanning electron micros-
copy (SEM).
Results: Mean ﬂuorescent intensity of platelets was signiﬁcantly less in the COBRA
PzF (74.51.3 AU) compared to COBRA BMS (97.86.7 AU, P<0.05) or Vision
BMS (108.26.9 AU, P<0.01). Percent thrombus area by SEM was signiﬁcantly less
in the COBRA PzF (5.6%) compared to COBRA BMS (7.0%, P<0.05) or Vision
BMS (69.1%, P<0.001).
Conclusions: The COBRA PzF stent signiﬁcantly reduces thrombogenicity in the
swine shunt model compared to Cobra BMS and Vision BMS.TCT Abstracts/POSTER/Basic Science, Animal Models, and Cell Therapy
